Accepts Healthy Volunteers
Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms
An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.
An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.
Searching Both is inclusive of interventional and observational studies.
|Eligible Ages||18 Years - 85 Years|
- - Age between 18 to 85 years.
- - Have regular follow up in Dermatology/ Rheumatology clinics of Queen Mary Hospital.
- - Diagnosed with PsO/PsA or RA.
- - Chinese ethnicity.
- - Age below 18 years or above 85 years.
- - Known decompensated cirrhosis.
- - Pregnancy or breastfeeding.
- - Unstable medical illness or active infection.
- - Unable to provide written consent.
- - Unable to adhere to the protocol.
- - Unable to read and/or write Chinese language.
- - On anticoagulant/ antiplatelet treatment.
- - Abnormal platelet count <150.
This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.
Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.
Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.
Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.
Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.
The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.
|The University of Hong Kong|
The person who is responsible for the scientific and technical direction of the entire clinical study.
|Sze-Man Wong, MSc, MRCP|
|Principal Investigator Affiliation||Queen Mary Hospital, Hong Kong|
Category of organization(s) involved as sponsor (and collaborator) supporting the trial.
|Overall Status||Not yet recruiting|
The disease, disorder, syndrome, illness, or injury that is being studied.
|Psoriasis Vulgaris, Rheumatoid Arthritis, Fibrosis, Liver|
Patients diagnosed with psoriasis or psoriatic arthritis
Patients diagnosed with rheumatoid arthritis
This trial has no sites locations listed at this time. If you are interested in learning more, you can contact the trial's primary contact:
Sze-Man Wong, MSc, MRCP
For additional contact information, you can also visit the trial on clinicaltrials.gov.